CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.

GUIDANCE:

CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.

For earnings history and earnings-related data on CVS Health (CVS) click here.